Stock Track | Medtronic Plunges 5.06% in Pre-market as Fiscal 2026 Guidance Falls Short of Estimates

Stock Track
Yesterday

Medtronic PLC's stock fell sharply by 5.06% in pre-market trading, following the release of the company's third-quarter fiscal 2026 financial results and updated guidance.

While the medical device maker reported strong quarterly performance, with adjusted earnings per share of $1.36 beating the IBES estimate of $1.33 and revenue of $9,000 million surpassing the $8,905 million estimate, investors focused on the company's outlook. Medtronic provided fiscal 2026 adjusted EPS guidance in the range of $5.62 to $5.66, which came in below the FactSet consensus estimate of $5.72.

The market's negative reaction highlights investor concerns over the company's future earnings potential, overshadowing the positive third-quarter results that included the highest enterprise revenue growth in ten quarters.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10